Follow
Michael Nagler
Michael Nagler
Department of Clinical Chemistry, Inselspital, Bern University Hospital, and University of Berne
Verified email at insel.ch
Title
Cited by
Cited by
Year
Diagnostic value of immunoassays for heparin-induced thrombocytopenia: a systematic review and meta-analysis
M Nagler, LM Bachmann, H Ten Cate, A ten Cate-Hoek
Blood, The Journal of the American Society of Hematology 127 (5), 546-557, 2016
1472016
Thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19-a Swiss consensus statement by the Working Party Hemostasis
A Casini, L Alberio, A Angelillo-Scherrer, P Fontana, B Gerber, L Graf, ...
Swiss medical weekly 150, w20247, 2020
1252020
Diagnostic accuracy of a SARS-CoV-2 rapid antigen test in real-life clinical settings
S Jegerlehner, F Suter-Riniker, P Jent, P Bittel, M Nagler
International Journal of Infectious Diseases 109, 118-122, 2021
1092021
Fondaparinux–data on efficacy and safety in special situations
M Nagler, M Haslauer, WA Wuillemin
Thrombosis research 129 (4), 407-417, 2012
1012012
A case of EDTA-dependent pseudothrombocytopenia: simple recognition of an underdiagnosed and misleading phenomenon
M Nagler, P Keller, D Siegrist, L Alberio
BMC Clinical Pathology 14, 1-4, 2014
782014
Cangrelor, tirofiban, and chewed or standard prasugrel regimens in patients with st-segment–elevation myocardial infarction: primary results of the FABOLUS-FASTER trial
G Gargiulo, G Esposito, M Avvedimento, M Nagler, P Minuz, G Campo, ...
Circulation 142 (5), 441-454, 2020
722020
Clinical and laboratory tests for the diagnosis of heparin-induced thrombocytopenia
M Nagler, T Bakchoul
Thrombosis and haemostasis 116 (11), 823-834, 2016
632016
Heparin-induced thrombocytopenia in cardiac surgery patients
AM Pishko, A Cuker
Seminars in thrombosis and hemostasis 43 (07), 691-698, 2017
592017
Thrombin generation measurement using the ST Genesia Thrombin Generation System in a cohort of healthy adults: normal values and variability
S Calzavarini, J Brodard, C Quarroz, L Maire, R Nützi, J Jankovic, ...
Research and practice in thrombosis and haemostasis 3 (4), 758-768, 2019
522019
Diagnostic utility of the ISTH bleeding assessment tool in patients with suspected platelet function disorders
M Adler, J Kaufmann, L Alberio, M Nagler
Journal of thrombosis and haemostasis 17 (7), 1104-1112, 2019
512019
Thromboembolism in patients with congenital afibrinogenaemia
M Nagler, JAK Hovinga, L Alberio, K Peter-Salonen, H von Tengg-Kobligk, ...
Thrombosis and haemostasis 116 (10), 722-732, 2016
442016
Prospective evaluation of the interobserver reliability of the 4Ts score in patients with suspected heparin‐induced thrombocytopenia
M Nagler, T Fabbro, WA Wuillemin
Journal of Thrombosis and Haemostasis 10 (1), 151-152, 2012
432012
Impact of rivaroxaban on point-of-care assays
P Fontana, L Alberio, A Angelillo-Scherrer, LM Asmis, W Korte, A Mendez, ...
Thrombosis research 153, 65-70, 2017
412017
Impact of changes in haematocrit level and platelet count on thromboelastometry parameters
M Nagler, S Kathriner, LM Bachmann, WA Wuillemin
Thrombosis Research 131 (3), 249-253, 2013
402013
Patient self-management of oral anticoagulation with vitamin K antagonists in everyday practice: efficacy and safety in a nationwide long-term prospective cohort study
M Nagler, LM Bachmann, P Schmid, P Raddatz Müller, WA Wuillemin
PloS one 9 (4), e95761, 2014
382014
Accuracy of serological testing for SARS‐CoV‐2 antibodies: first results of a large mixed‐method evaluation study
D Brigger, MP Horn, LF Pennington, AE Powell, D Siegrist, B Weber, ...
Allergy 76 (3), 853-865, 2021
362021
Association of anemia and hemoglobin decrease during acute stroke treatment with infarct growth and clinical outcome
S Bellwald, R Balasubramaniam, M Nagler, MS Burri, SDA Fischer, ...
PloS one 13 (9), e0203535, 2018
362018
Epistaxis in anticoagulated patients: Fewer hospital admissions and shorter hospital stays on rivaroxaban compared to phenprocoumon
TC Sauter, K Hegazy, WE Hautz, G Krummrey, ME Ricklin, M Nagler, ...
Clinical otolaryngology 43 (1), 103-108, 2018
352018
Comparative effectiveness and safety of anticoagulants for the treatment of heparin‐induced thrombocytopenia
H Nilius, J Kaufmann, A Cuker, M Nagler
American journal of hematology 96 (7), 805-815, 2021
332021
Accuracy and consistency of anti‐Xa activity measurement for determination of rivaroxaban plasma levels
JD Studt, L Alberio, A Angelillo‐Scherrer, LM Asmis, P Fontana, W Korte, ...
Journal of thrombosis and haemostasis 15 (8), 1576-1583, 2017
292017
The system can't perform the operation now. Try again later.
Articles 1–20